|
Market Closed -
Nasdaq
16:00:00 2026-08-31 EDT
|
5-day change | 1st Jan Change | ||
| 47.26 USD | -0.98% |
|
-1.97% | +112.31% |
| 08-11 | LB Pharmaceuticals Inc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 08-11 | LB Pharmaceuticals Q2 Loss Per Share Narrows | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| LB PHARMACEUTICALS INC | Bio Therapeutic Drugs | -0.98% | -1.97% | +112.31% | - | - | 1.52B |  | | |
- Stock Market
- Stocks
- LBRX Stock
- Charts LB Pharmaceuticals Inc
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
